Despite the fact that cirrhosis is a frequent cause of death among patients with NAFLD and diabetes type 2, it has been shown that mortality due to cardiovascular events actually masks the real mortality rate due to hepatic causes 77, 78. 19% of deaths among these patients are due to cardiac events, 16% to cerebral vascular events, 13% to renal failure, and 6% are hepatic.
En relación a la mortalidad del NAFLD en pacientes con diabetes tipo 2 u obesidad, se ha encontrado que la mortalidad cardiovascular enmascara la mortalidad por causas hepáticas 77, 78, de forma que a pesar de que la cirrosis es una causa frecuente de muerte, 19% murieron de eventos cardíacos, 16% cerebrovasculares, 13% renales y 6% hepáticas.